VanEck Associates’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25K | Buy |
1,451
+147
| +11% | +$2.53K | ﹤0.01% | 1348 |
|
|
2025
Q1 | $25K | Buy |
1,304
+316
| +32% | +$6.06K | ﹤0.01% | 1330 |
|
|
2024
Q4 | $25K | Buy |
988
+138
| +16% | +$3.49K | ﹤0.01% | 1329 |
|
|
2024
Q3 | $19K | Sell |
850
-190
| -18% | -$4.25K | ﹤0.01% | 1315 |
|
|
2024
Q2 | $24K | Sell |
1,040
-105
| -9% | -$2.42K | ﹤0.01% | 1320 |
|
|
2024
Q1 | $38K | Hold |
1,145
| – | – | ﹤0.01% | 1293 |
|
|
2023
Q4 | $31K | Buy |
1,145
+57
| +5% | +$1.54K | ﹤0.01% | 1310 |
|
|
2023
Q3 | $26K | Hold |
1,088
| – | – | ﹤0.01% | 1323 |
|
|
2023
Q2 | $35K | Hold |
1,088
| – | – | ﹤0.01% | 1320 |
|
|
2023
Q1 | $33K | Sell |
1,088
-36
| -3% | -$1.09K | ﹤0.01% | 1332 |
|
|
2022
Q4 | $44K | Buy |
1,124
+408
| +57% | +$16K | ﹤0.01% | 1322 |
|
|
2022
Q3 | $34K | Buy |
+716
| New | +$34K | ﹤0.01% | 1291 |
|